Description:The peptide is used to block Anti-SSX-pan Antibody (#CPA2107) reactivity.Form:Lyophilized powderGene Symbol:SSX1; SSX2; SSX3; SSX4; SSX5; SSX6; SSX7; SSX8; SSX9Alternative Names:SSX1; Protein SSX1; Cancer/testis antigen 5.1; CT5.1; Synovial sarcoma, X breakpoint 1; SSX2; SSX2A; SSX2B; Protein SSX2; Cancer/testis antigen 5.2; CT5.2; Synovial sarcoma, X breakpoint 2; Tumor antigen HOM-MEL-40; SSX3; Protein SSX3; Cancer/testis antigen 5.3; CT5.3; SSX4; SSX4A; SSX4B; Protein SSX4; Cancer/testis antigen 5.4; CT5.4; SSX5; Protein SSX5; SSX6; Putative protein SSX6; SSX7; Protein SSX7; SSX8; Protein SSX8; SSX9; Protein SSX9
Entrez Gene (Human):
6756;
6757;
727837;
10214;
548313;
6759;
6758;
280658;
SwissProt (Human):
Q16384;
Q16385;
Q99909;
O60224;
O60225;
Q7RTT6;
Q7RTT5;
Q7RTT4;
Q7RTT3;
Purity:>85%Directions for Use:Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours.Quality Control:The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry.Storage/Stability:Shipped at 4°C. Store at -20°C for one year.